Early lessons from the integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 7, 2008, Pages 773-779

  Harris, Jennifer B ^a,b   Hatwiinda, S M ^a   Randels, K M ^a   Chi, B H ^a,b   Kancheya, N G ^a   Jham, M A ^a   Samungole, K V G ^c   Tambatamba, B C ^c   Cantrell, R A ^a,b   Levy, J W ^a,b   Kimerling, M E ^b   Reid, S E ^a,b  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Lusaka District Health Management Team   (Zambia)

Author keywords

Diagnostic counseling and testing; TB HIV integration; Zambia

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ARTICLE; CD4 LYMPHOCYTE COUNT; HEALTH CENTER; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PATIENT CARE; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; URBAN AREA; ZAMBIA;

ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; COMMUNITY HEALTH SERVICES; COMORBIDITY; DELIVERY OF HEALTH CARE; DELIVERY OF HEALTH CARE, INTEGRATED; HIV INFECTIONS; HUMANS; NATIONAL HEALTH PROGRAMS; PRIMARY HEALTH CARE; TUBERCULOSIS; ZAMBIA;

EID: 47149095063     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. World Health Organization. WHO report 2007. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: WHO, 2007.
2. Joint United Nations Programme on HIV/AIDS. Zambia country profile. Geneva, Switzerland: UNAIDS. http://www.unaids.org/en/Regions_Countries/ Countries/zambia.asp Accessed October 2007.
3. Kaminsa-Kabanje S, Jham M, Kancheya N, Jurkuvenas V, Kimerling M, Reid S. Integration of tuberculosis (TB) and HIV care in primary health care services in Lusaka, Zambia. In: XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006. Abstract MOPE0168. Cointrin, Switzerland: International AIDS Society, 2006.
4. Stringer J S, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296: 782-793.
5. Bolton-Moore C, Mubiana-Mbewe M, Cantrell R A, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007; 298: 1888-1899.
6. Chi B H, Fusco H, Sinkala M, Goldenberg R L, Stringer J S. Cost and enrollment implications of targeting different source population for an HIV treatment program. J Acquir Immune Defic Syndr 2005; 40: 350-355.
7. Reid A, Scano F, Getahun H, et al. Towards universal access to HIV prevention, treatment, care and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006; 6: 483-495.
8. Bwire R, Nagelkerke N J, Borgdorff M W. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment. Trop Med Int Health 2006; 11: 1567-1575.
9. Abdool-Karim S S, Abdool-Karim Q, Friedland G, Lalloo U, El-Sadr W M. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS 2004; 18: 975-979.
10. Nunn P, Reid A, De Cock K M. Tuberculosis and HIV infection: the global setting. J Infect Dis 2007; 196 (Suppl 1): S5-S14.
11. Harries A D, Hargreaves N J, Chimzizi R, Salaniponi F M. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bull World Health Organ 2002; 80: 464-469.
12. Friedland G, Abdool Karim S, Abdool Karim Q, et al. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Clin Infect Dis 2004; 38 (Suppl 5): S421-S428.
13. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol 2005; 5: 819-826.
14. World Health Organization. The Stop TB strategy: building on and enhancing DOTS to meet the TB-related millennium development goals. WHO/HTM/STB/2006.37. Geneva, Switzerland: WHO, 2006.
15. Ministry of Health of the Republic of Zambia. Guidelines for TB-HIV integration. Lusaka, Zambia: MOH, 2006.
16. World Health Organization. Interim policy on collaborative TB-HIV activities. WHO/HTM/TB/2004.330. WHO/HTM/HIV/2004.1. Geneva, Switzerland: WHO, 2004.
17. Morris M, Bolton C, Mwanza J, et al. Ensuring quality patient care during rapid scale up of antiretroviral (ARV) therapy in Zambia. In: XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006. Abstract THPE0224. Cointrin, Switzerland: International AIDS Society, 2006.
18. World Health Organization and Joint United Nations Programme on HIV/AIDS. Guidance on provider-initiated HIV testing and counseling in health facilities. Geneva, Switzerland: WHO, 2007.
19. Chi B H, Chintu N, Lee A, Stringer E M, Sinkala M, Stringer J S. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia. J Acquir Immune Defic Syndr 2007; 45: 125-127.
20. Fusco H, Hubschman T, Mweeta V, et al. Electronic patient tracking supports rapid expansion of HIV care and treatment in resource-constrained settings. In: 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, July 24-27, 2005. Abstract MoPe11.2C37. Cointrin, Switzerland: International AIDS Society, 2005.
21. Zachariah R, Spielmann M P, Chinji C, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003; 17: 1053-1061.
22. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis 2007; 196 (Suppl 1): S114-S123.
23. Murray L K, Thea D, Bolton P, et al. What are the causes of reduced ARV adherence in Africa? A hypothesis generating study from Zambia. HIV/AIDS Implementers' Meeting, Kigali, Rwanda, 2007. Abstract 1642.
24. Bond V. The importance of addressing the unfolding TB-HIV stigma in high HIV prevalence settings. J Community Applied Social Psychol 2006; 16: 452-461.
25. Hardon A P, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007; 19: 658-665.
26. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42-46.
27. Schiffer J T, Sterling T R. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr 2007; 44: 229-234.
28. Lawn S D, Wood R. When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa? S Afri Med J 2007; 97: 412, 414-415.
29. Harries A D, Boxshall M, Phiri S, et al. Providing HIV care for tuberculosis patients in sub-Saharan Africa. Int J Tuberc Lung Dis 2006; 10: 1306-1311.
30. Zachariah R, Teck R, Ascurra O, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis 2005; 9: 238-247.
31. Chi B H, Sinkala M, Stringer E M, et al. Employment of off-duty staff: a strategy to meet the human resource needs for a large PMTCT program in Zambia. J Acquir Immune Defic Syndr 2005; 40: 381-382.